Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations
出版年份 2011 全文链接
标题
Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 103, Issue 8, Pages 674-688
出版商
Oxford University Press (OUP)
发表日期
2011-03-14
DOI
10.1093/jnci/djr070
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human Diseases
- (2010) Heather A. Hirsch et al. CANCER CELL
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study
- (2009) Jeeyun Lee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro
- (2009) Jacek Bil et al. CANCER LETTERS
- Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer
- (2009) R Seth et al. GUT
- Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations
- (2009) In Hae Park et al. INVESTIGATIONAL NEW DRUGS
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs
- (2009) Seiichi Mori et al. PLoS One
- KRAS mutations predict response to EGFR inhibitors
- (2008) Mitch Raponi et al. CURRENT OPINION IN PHARMACOLOGY
- Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic
- (2008) Mark S. Cragg et al. JOURNAL OF CLINICAL INVESTIGATION
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab
- (2008) Astrid Lièvre et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutant B-RAF mediates resistance to anoikis via Bad and Bim
- (2008) K Boisvert-Adamo et al. ONCOGENE
- Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20
- (2008) Magdalena Winiarska et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now